Arcturus Therapeutics Holdings (ARCT) Earnings Date & Reports

Industry: @Pharmaceuticals Major

A.I. Advisor

published Earnings

ARCT is expected to report earnings to fall 10.94% to -56 cents per share on November 06

Arcturus Therapeutics Holdings ARCT Stock Earnings Reports

Q3'24

Est.

$-0.57

Q2'24

Beat

by $0.38

Q1'24

Beat

by $0.06

Q4'23

Beat

by $0.63

Q3'23

Beat

by $1.01

The last earnings report on August 05 showed earnings per share of -63 cents, beating the estimate of -101 cents. With 371.32K shares outstanding, the current market capitalization sits at 595.74M.

View a ticker or compare two or three

Compare

ARCT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ARCT
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ARCT (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of technology and therapeutics for rare diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

10628 Science Center Drive

Phone

+1 858 900-2660

Employees

180

Web

https://www.arcturusrx.com